Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Puma Biotechnology Inc (NASDAQ:PBYI)

40.60
Delayed Data
As of Apr 28
 +0.65 / +1.63%
Today’s Change
19.74
Today|||52-Week Range
73.27
+32.25%
Year-to-Date
No recent news for Puma Biotechnology Inc.

Today’s Trading

Previous close39.95
Today’s open39.90
Day’s range38.10 - 41.00
Volume1,053,214
Average volume (3 months)924,538
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-11.28%
Earnings growth (this year)-0.43%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.13

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-0.45-1.01%
ARRYArray Biopharma Inc-0.03-0.34%
DERMDermira Inc+0.22+0.65%
EGRXEagle Pharmaceutical...+0.07+0.08%
Data as of 4:14pm ET, 04/28/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$1.97
Annual revenue (last year)$0.00
Annual profit (last year)-$276.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Alan H. Auerbach
Treasurer &
Senior VP-Finance & Administration
Charles R. Eyler
Corporate headquarters
Los Angeles, California

Forecasts